Shop
-
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
-
Sprycel (Dasatinib) – Leukemias | HongKong DengYue Medicine
-
Bimzelx (Bimekizumab) – Psoriasis | HongKong DengYue Medicine
-
Xgeva (Denosumab) – GCTB | HongKong DengYue Medicine
-
Emgality (Galcanezumab) – Anti-Migraine | HongKong DengYue Medicine
-
Eloxatin (Oxaliplatin) – Colorectal Cancer | HongKong DengYue Medicine
-
Caprelsa (Vandetanib) – MTC | HongKong DengYue Medicine
-
Romlusevimab – COVID-19 | HongKong DengYue Medicine
-
Orthocone OKT3 (Muromonab-CD3) – Prevention and Treatment of Acute Rejection | HongKong DengYue Medicine
-
Jinbeixin (Firsekibart) – Gouty Arthritis (GA) | HongKong DengYue Medicine
-
Cabometyx (Cabozantinib) – Solid Tumors | HongKong DengYue Medicine
-
Tivdak (Tisotumab Vedotin) – Uterine Cervical Neoplasms | HongKong DengYue Medicine
-
Verzenio (Abemaciclib) – Breast Cancer | HongKong DengYue Medicine
-
Saimeina (Befotertinib) – NSCLC | HongKong DengYue Medicine
-
HICARA – r/r LBCL | HongKong DengYue Medicine
-
Rujianing (Lerociclib) – Breast Cancer | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights